FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+18.27%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.08B
AUM Growth
+$1.08B
(+9%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
1.63%
Top 10 Holdings %
Top 10 Hldgs %
53.14%
Holding
94
New
23
Increased
12
Reduced
34
Closed
20
Top Buys
Top Sells
| 1 |
MODN
MODEL N, INC.
MODN
|
$13.2M |
| 2 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$12.5M |
| 3 |
Mirum Pharmaceuticals
MIRM
|
$11M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$10.2M |
| 5 |
CareDx
CDNA
|
$9.36M |
Sector Composition
| 1 | Healthcare | 86.01% |
| 2 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MODN
1
DELISTED
MODEL N, INC.
MODN
| $92.6M | 8.59% | 2,282,621 -325,600 | -12% | -$13.2M |
|
2
Prothena Corp
PRTA
$441M
| $92.5M | 8.59% | 1,535,599 -3,079 | -0.2% | -$186K |
|
|
RETA
3
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $78.4M | 7.27% | 2,062,453 +1,007,468 | +95% | +$38.3M |
|
4
AtriCure
ATRC
$1.84B
| $64.5M | 5.98% | 1,452,514 -42,141 | -3% | -$1.87M |
|
|
SPNE
5
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $57.4M | 5.33% | 6,877,650 -189,922 | -3% | -$1.59M |
|
6
Halozyme
HALO
$8.56B
| $52.5M | 4.88% | 923,119 -9,125 | -1% | -$519K |
|
7
Krystal Biotech
KRYS
$4.27B
| $37.5M | 3.48% | 473,691 -18,864 | -4% | -$1.49M |
|
8
Alphatec Holdings
ATEC
$2.35B
| $36.1M | 3.35% | 2,926,173 -48,485 | -2% | -$599K |
|
|
KRTX
9
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $32.3M | 3% | 164,615 -1,701 | -1% | -$334K |
|
10
SI-BONE Inc
SIBN
$719M
| $28.6M | 2.66% | 2,105,453 +77,490 | +4% | +$1.05M |
|
11
Keros Therapeutics
KROS
$618M
| $28.4M | 2.64% | 592,412 -5,801 | -1% | -$279K |
|
|
PHLT
12
Performant Healthcare, Inc. Common Stock
PHLT
$603M
| $26.7M | 2.48% | 7,387,280 +2,367,173 | +47% | +$8.55M |
|
13
Tandem Diabetes Care
TNDM
$845M
| $26.3M | 2.45% | 586,150 +100,530 | +21% | +$4.52M |
|
|
CUTR
14
DELISTED
Cutera, Inc.
CUTR
| $25.1M | 2.33% | 567,139 -196,041 | -26% | -$8.67M |
|
15
NeoGenomics
NEO
$1.13B
| $24.8M | 2.3% | 2,682,171 -37,928 | -1% | -$350K |
|
16
Crinetics Pharmaceuticals
CRNX
$2.92B
| $24.3M | 2.26% | 1,329,313 -17,339 | -1% | -$317K |
|
17
Axogen
AXGN
$743M
| $23.7M | 2.2% | 2,371,848 -539,976 | -19% | -$5.39M |
|
|
FNA
18
DELISTED
Paragon 28, Inc.
FNA
| $23.6M | 2.19% | 1,236,262 -1,793 | -0.1% | -$34.3K |
|
19
KORU Medical Systems
KRMD
$195M
| $22.6M | 2.1% | 6,338,082 +64,309 | +1% | +$230K |
|
|
BCYC
20
Bicycle Therapeutics
BCYC
$511M
| $20.6M | 1.91% | 696,432 -8,289 | -1% | -$245K |
|
21
Pliant Therapeutics
PLRX
$101M
| $20.4M | 1.9% | 1,057,881 +92,767 | +10% | +$1.79M |
|
|
AXNX
22
DELISTED
Axonics, Inc. Common Stock
AXNX
| $19.4M | 1.8% | 310,449 -6,360 | -2% | -$398K |
|
|
BLU
23
DELISTED
BELLUS Health Inc.
BLU
| $19.4M | 1.8% | 2,356,950 -24,907 | -1% | -$205K |
|
24
Omnicell
OMCL
$1.5B
| $17.4M | 1.61% | 344,151 -4,955 | -1% | -$250K |
|
25
Transmedics
TMDX
$3.92B
| $16.4M | 1.52% | 265,097 +111,328 | +72% | +$6.87M |
|